Luciferase Reporter Cell Line - THP-1

Cell Line THP-1 originates from the peripheral blood of a 1-year-old boy diagnosed with acute monocytic leukemia. Since its establishment in 1980, THP-1 cells have been widely utilized in studies pertaining to immunological responses, inflammatory signaling pathways, and mechanisms connected to monocytes and macrophages. THP-1 cells are suspension cells that share more physical and functional traits—such as cell differentiation markers—with primary human monocytes than leukemia cell lines like ML-2, HL-60, and U937. In addition, THP-1 cells have a more stable genetic background than peripheral blood mononuclear cells (PBMCs), which reduces the inherent individual variances in PBMCs and makes result reproducibility easier. This makes THP-1 cells easier to cultivate and grow in the lab. As a result, THP-1 is a commonly utilized cell line in labs researching acute monocytic leukemia and is a perfect tool for examining inflammation and immunological responses. The THP-1 luciferase reporter cell line is designed to express a luciferase reporter gene that is regulated by components that react to particular stimuli. Using the luciferase gene as a molecular beacon, scientists may track real-time alterations in signaling pathways or gene expression.